Immunocore Holdings(IMCR)
$29.94-0.54 (-1.76%)
IMCR
Immunocore Holdings Revenue
$29.94
At close:-0.54 (-1.76%)
Want to see IMCR full AI Analyst Report?
Immunocore Holdings (IMCR) Revenue
258 Followers
Immunocore Holdings Revenue
Immunocore Holdings had a revenue of 102.22M in the quarter ending Sep 30, 2026, with -11.82%. This bring the company's revenue in the last twelve months to 429.30M, Decreased 0.34%. In the fiscal year ending Dec 31, 2025, Immunocore Holdings had annual revenue of 400.02M with 28.84% growth.
- Revenue (ttm)
- 429.30M
- Revenue Growth
- 13.01%
- P/S Ratio
- 3.86
- Revenue/Employee
- $763,389
- Employees
- 524
- Market Cap
- $1.55B
Revenue Chart
Immunocore Holdings Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 400.02M | 89.53M | 28.84% |
| Dec 31, 2024 | 310.48M | 113.10M | 57.30% |
| Dec 31, 2023 | 197.39M | 53.15M | 36.85% |
| Dec 31, 2022 | 144.23M | 117.19M | 433.32% |
| Dec 31, 2021 | 27.04M | -3.07M | -10.19% |
| Dec 31, 2020 | 30.11M | 4.45M | 17.32% |
| Dec 31, 2019 | 25.67M | 2.02M | 8.52% |
| Dec 31, 2018 | 23.65M | 9.21M | 63.74% |
| Dec 31, 2017 | 14.45M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

